Log in
Enquire now
‌

US Patent 11667687 Masked activatable interferon constructs

Patent 11667687 was granted and assigned to CytomX Therapeutics on June, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
0
Date Filed
March 16, 2022
0
Date of Patent
June 6, 2023
0
Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
0
Patent Application Number
17696222
0
Patent Citations
‌
US Patent 8734774 Protease activated cytokines
0
‌
US Patent 8809504 Inhibitor which is deactivatable by a reagent produced by a target cell
0
‌
US Patent 9453078 Modified antibody compositions, methods of making and using thereof
0
‌
US Patent 9675672 Compositions and methods for modulating gamma-C-cytokine activity
0
‌
US Patent 10059762 Anti-EGFR activatable antibodies
0
‌
US Patent 10077300 Activatable binding polypeptides and methods of identification and use thereof
0
‌
US Patent 10118961 Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
0
‌
US Patent 10513549 Cleavage-activatable interferon-alpha proprotein
0
‌
US Patent 10683368 Fc-region variants with modified FcRn-binding and methods of use
0
‌
US Patent 10696723 Activatable interleukin 12 polypeptides
0
•••
Patent Citations Received
‌
US Patent 12091442 Activatable cytokine constructs and related compositions and methods
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11667687
0
Patent Primary Examiner
‌
Elly-Gerald Stoica
0
CPC Code
‌
C07K 14/555
0
‌
C07K 2319/50
0
‌
C07K 2319/00
0

Find more entities like US Patent 11667687 Masked activatable interferon constructs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo